Atreca, Inc.
BCELDelisted Mar 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001532346
Atreca, Inc. was delisted on Mar 20, 2024; its insiders filed their last Form 4 on Apr 17, 2024; 43 institutions reported holding it in 13F filings for Q4 2023, worth $1.24M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Atreca, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 53 | 1 | 45 | −7 |
| Shares | 13.7M | 10.6K | 12.4M | −1.24M (−9.1%) |
| Value | $13.4M | $10.0K | $3.24M | −$10.1M (−75.8%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Atreca, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 26,181 | $6.83K | 0.00% |
| ERn Financial, LLC | 21,702 | $5.66K | 0.00% |
| Qube Research & Technologies Ltd | 52 | $14 | 0.00% |
| Authentikos Wealth Advisory, LLC | 23 | $6 | 0.00% |
| Bank of America Corp | 1 | $0 | 0.00% |
Sold out (12)
Institutions that held Atreca, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| ExodusPoint Capital Management, LP | 466,828 | $457.0K |
| Cormorant Asset Management, LP | 319,057 | $312.7K |
| Dimensional Fund Advisors LP | 38,994 | $38.2K |
| HighTower Advisors, LLC | 24,811 | $24.0K |
| Virtu Financial LLC | 14,239 | $14.0K |
| Sand Hill Global Advisors, LLC | 12,500 | $12.3K |
| Group One Trading, L.P. | 5,000 | $4.90K |
| Royal Bank of Canada | 1,009 | $1.00K |
| Northwestern Mutual Wealth Management Co | 500 | $490 |
| Citadel Advisors LLC | 440 | $431 |
| Tower Research Capital LLC (TRC) | 213 | $209 |
| Salem Investment Counselors Inc | 85 | $84 |
Not filed for Q3 2023 yet (1)
Institutions that held Atreca, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Endurance Wealth Management, Inc. | 10,600 | $10.0K |